Cardiovascular safety of metformin and sulfonylureas in patients with different cardiac risk profiles. [electronic resource]
Producer: 20170717Description: 1544-51 p. digitalISSN:- 1468-201X
- Aged
- Austria
- Biomarkers -- blood
- Cardiovascular Diseases -- blood
- Chi-Square Distribution
- Diabetes Mellitus, Type 2 -- blood
- Female
- Humans
- Hypoglycemic Agents -- adverse effects
- Male
- Metformin -- adverse effects
- Middle Aged
- Natriuretic Peptide, Brain -- blood
- Peptide Fragments -- blood
- Proportional Hazards Models
- Prospective Studies
- Protective Factors
- Risk Assessment
- Risk Factors
- Sulfonylurea Compounds -- adverse effects
- Time Factors
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Multicenter Study; Observational Study
There are no comments on this title.
Log in to your account to post a comment.